Opin vísindi

An investigation on the use of snus and its association with respiratory and sleep-related symptoms: a cross-sectional population study

An investigation on the use of snus and its association with respiratory and sleep-related symptoms: a cross-sectional population study


Titill: An investigation on the use of snus and its association with respiratory and sleep-related symptoms: a cross-sectional population study
Höfundur: Guðnadóttir, Arna Ýr
Ólafsdóttir, Inga Sif
Middelveld, Roelinde
Ekerljung, Linda
Forsberg, Bertil
Franklin, Karl
Lindberg, Eva
Janson, Christer
Útgáfa: 2017-05
Tungumál: Enska
Umfang: e015486
Háskóli/Stofnun: Háskóli Íslands
University of Iceland
Svið: Heilbrigðisvísindasvið (HÍ)
School of Health Sciences (UI)
Deild: Læknadeild (HÍ)
Faculty of Medicine (UI)
Birtist í: BMJ Open;7(5)
ISSN: 2044-6055
DOI: 10.1136/bmjopen-2016-015486
Efnisorð: Munntóbak; Asma; Öndunarfærasjúkdómar; Svefntruflanir; Spurningalistar
URI: https://hdl.handle.net/20.500.11815/333

Skoða fulla færslu

Tilvitnun:

Gudnadóttir AÝ, Ólafsdóttir IS, Middelveld R, et al An investigation on the use of snus and its association with respiratory and sleep-related symptoms: a cross-sectional population study BMJ Open 2017;7:e015486. doi: 10.1136/bmjopen-2016-015486

Útdráttur:

Introduction Studies of the health effects of moist oral tobacco, snus, have produced inconsistent results. The main objective of this study is to examine the health effects of snus use on asthma, respiratory symptoms and sleep-related problems, a field that has not been investigated before. Methods and material This cross-sectional study was based on a postal questionnaire completed by 26 697 (59.3%) participants aged 16 to 75 years and living in Sweden. The questionnaire included questions on tobacco use, asthma, respiratory symptoms and sleeping problems. The association of snus use with asthma, respiratory symptoms and sleep-related symptoms was mainly tested in never-smokers (n=16 082). Results The current use of snus in never-smokers was associated with an increased risk of asthma (OR 1.51 (95% CI 1.28 to 1.77)), asthmatic symptoms, chronic bronchitis and chronic rhinosinusitis. This association was not present among ex-snus users. Snoring was independently related to both the former and current use of snus ((OR 1.37 (95% CI 1.12 to 1.68)) and (OR 1.59 (95% CI 1.34 to 1.89), respectively)). A higher risk of difficulty inducing sleep was seen among snus users. Conclusion Snus use was associated with a higher prevalence of asthma, respiratory symptoms and snoring. Healthcare professionals should be aware of these possible adverse effects of snus use.

Leyfi:

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:


Fletta

Um vefinn

Reikningurinn minn